PF-Atlas › Clinical Trials › NCT00846781
Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease
Denufosol tetrasodium Inhalation Solution · Phase 3
Registry ID
NCT00846781
Phase
Phase 3
Status
Terminated
Drug / intervention
Denufosol tetrasodium Inhalation Solution
Sponsor
Merck Sharp & Dohme LLC
Start
2009-02
Enrollment
308
About this trial
The purpose of this study is to obtain data on the potential of long-term treatment with denufosol to improve the clinical course of CF lung disease in patients with mildly impaired lung function and to provide CF patients who completed study 08-110 continued access to denufosol.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT00846781 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.